Skip to main content

Table 1 Clinical and biochemical characteristics in NAFLD patients and controls subjects

From: Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)

 

PATIENTS (n=35)

CONTROLS (n=51)

P

Total Cholesterol

187.91 ± 38.83

182.27 ± 38.36

0.516

HDL

44.30 ± 13.83

53.51 ± 15.27

0.006*

LDL

115.49 ± 35.88

110.46 ± 32.38

0.509

Triglycerides

171.72 ± 80.91

93.77 ± 39.70

p< 0.001*

Fasting Glucose

99.67 ± 35.59

92.09 ± 10.50

0.167

Insulin

16.55 ± 10.74

7.12 ± 4.22

p < 0.001*

HOMA value >3.0

3.90 ± 2.75

1.65 ± 1.10

p < 0.001*

AST

54.51 ± 31.94

18.20 ± 5.93

p< 0.001*

ALT

82.15 ± 38.72

14.82 ± 8.99

p < 0.001*

GGT

126.38 ± 125.90

28.35 ± 22.61

p< 0.001*

AP

87.15 ± 53.88

63.92 ± 33.53

0.019*

BMI

29.77 ± 4.38

24.22 ± 3.68

p < 0.001*

  1. * t-Test was applied for these groups specifically. BMI. body mass index; HDL-C. high-density-lipoprotein cholesterol; LDL-C. Low-density- lipoprotein cholesterol.
Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us